| DC Field | Value | Language |
|---|
| dc.contributor.author | Osipova, O. A. | - |
| dc.contributor.author | Zhernakova, N. I. | - |
| dc.contributor.author | Dobromirova, E. V. | - |
| dc.contributor.author | Golovin, A. I. | - |
| dc.date.accessioned | 2020-02-26T07:44:09Z | - |
| dc.date.available | 2020-02-26T07:44:09Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Renoprotective effects of 3 HMG reductase blockers in elderly patients with acute coronary syndrome undergoing revascularization through percutaneous coronary intervention / O.A. Osipova [et al.] // Revista Latinoamericana de Hipertensión. - 2019. - Vol.14, №4.-P. 314-318. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/28722 | - |
| dc.description.abstract | This literature review presents current data on statins as anti-inflammatory agents in atherogenesis. Analyzed the results of several randomized clinical trials | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | cardiology | ru |
| dc.subject | acute coronary syndrome | ru |
| dc.subject | statins | ru |
| dc.subject | chronic kidney disease | ru |
| dc.subject | reductase blockers | ru |
| dc.subject | renoprotective effects | ru |
| dc.subject | anti-inflammatory agents | ru |
| dc.subject | clinical trials | ru |
| dc.title | Renoprotective effects of 3 HMG reductase blockers in elderly patients with acute coronary syndrome undergoing revascularization through percutaneous coronary intervention | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
